Status:

RECRUITING

AusCADASIL: An Australian Cohort of CADASIL

Lead Sponsor:

Perminder Sachdev

Collaborating Sponsors:

Prince of Wales Hospital, Sydney

John Hunter Hospital

Conditions:

Cadasil

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this project is to establish an Australian cohort of patients diagnosed with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). This study...

Detailed Description

Using clinical examination, questionnaires, neuropsychological evaluation, brain MRI, blood sample evaluation and retinal imaging, we aim to characterise the clinical profile and progression of CADASI...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Adults ≥18 years old
  • Ability to provide written informed consent
  • A large-print version is available for individuals with visual impairment
  • An easy-to-read version is available for individuals with cognitive difficulties who may require extra support
  • Ability to attend a testing site
  • Ability to complete minimum dataset (medical examination and medical history questionnaire, blood test to determine genetic status and a short (20 minute) neuropsychology assessment).
  • CADASIL participants according to one of the following categories:
  • confirmed diagnosis via genetic testing (NOTCH3 pathogenic variant), OR
  • suspected diagnosis based on medical history and brain MRI, OR
  • first degree relative of participant who is positive for NOTCH3 pathogenic variant
  • OR 6. Unrelated individual who is negative for the NOTCH3 pathogenic variant, and has no cognitive complaints (i.e. control participant)
  • Exclusion criteria:
  • 1\. Significant cognitive impairment leading to an inability to provide informed consent.

Exclusion

    Key Trial Info

    Start Date :

    November 25 2023

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    March 31 2027

    Estimated Enrollment :

    300 Patients enrolled

    Trial Details

    Trial ID

    NCT06148051

    Start Date

    November 25 2023

    End Date

    March 31 2027

    Last Update

    May 8 2024

    Active Locations (5)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (5 locations)

    1

    John Hunter Hospital

    Newcastle, New South Wales, Australia, 2305

    2

    Prince of Wales Hospital

    Sydney, New South Wales, Australia, 2031

    3

    University of New South Wales

    Sydney, New South Wales, Australia, 2031

    4

    Royal Brisbane and Women's Hospital

    Brisbane, Queensland, Australia, 4006

    AusCADASIL: An Australian Cohort of CADASIL | DecenTrialz